Rabinowicz, Adrian L. http://orcid.org/0000-0003-1299-0606
Carrazana, Enrique http://orcid.org/0000-0001-8788-0722
Maggio, Edward T. http://orcid.org/0000-0001-7808-9963
Funding for this research was provided by:
Neurelis, Inc.
Article History
Accepted: 8 August 2021
First Online: 25 August 2021
Declarations
:
: Development of this manuscript was supported by Neurelis, Inc., which also sponsored open access.
: Adrian L. Rabinowicz is an employee of and has received stock options from Neurelis, Inc. Enrique Carrazana is an employee of and has received stock and stock options from Neurelis, Inc. Edward T. Maggio is a consultant to Neurelis, Inc.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article; no datasets were generated or analyzed during the current study.
: Not applicable.
: ETM provided initial interpretation of the studies. All authors provided additional interpretation, developed the initial outline, and contributed to the manuscript. All authors meet International Committee of Medical Journal Editors criteria for authorship. All authors approved the final version of this manuscript and agreed to submit to <i>Drugs in R&D.</i>